Australian patients using products containing delta-8 THC to manage conditions including PTSD, chronic pain, anxiety and insomnia have been left in limbo following a TGA crackdown on the cannabinoid, Cannabiz has learned.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

TGA boss Professor John Skerritt confirmed last month that products containing delta-8 which has been chemically transformed from CBD are not legal in Australia, a position the regulator reaffirmed in its long-awaited reforms to TGO93.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...